Skip to main content

Table 1 Source studies

From: Statin cost effectiveness in primary prevention: A systematic review of the recent cost-effectiveness literature in the United States

Study, 1st Author Year Population Drug Studied Time Horizon Outcome Measured
Prosser LA 2000 Age 35-84, LDL >159 Pravastatin 30 years QALY
Caro JJ 2003 Age >45 Pravastatin 5 years LYG
Pignone M 2006 45-year old men Pravastatin Lifetime QALY
Pletcher MJ 2009 Age >35 All statins 30 years QALY
  1. Methodological differences among studies. QALY, quality adjusted life year; LYG, life year gained; LDL, low density lipoprotein cholesterol.